Fourth Avenue Cardiac Clinic

04/06/2026

03/24/2026

Share this infographic with your patients to explain high Lp(a), why knowing levels is important, and its impact on heart health.

Learn more: https://bit.ly/4rMSOal

03/13/2026

🆕 ACC/AHA Guideline on the Management of Dyslipidemia offers a comprehensive “one-stop shop” for addressing the evaluation, management and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated Lp[a].

The document consolidates evidence-based recommendations for managing dyslipidemias and retires and replaces the 2018 Guideline on the Management of Blood Cholesterol.

Read the full guideline in : https://bit.ly/4cLB0J0

03/12/2026

Through ACC’s Cardiac : Accelerating Diagnosis and Treatment online course, build confidence in recognizing the key symptoms and clinical clues of cardiac amyloidosis, selecting the right diagnostic tests and understanding treatment pathways. With interactive activities, podcasts, case quizzes and more, learn about the essential role of the multidisciplinary care team in delivering timely, comprehensive care.

Learn more: https://bit.ly/46QADsV

03/07/2026

Fluid restriction in patients with heart failure: a systematic review

https://heart.bmj.com/content/early/2026/01/13/heartjnl-2025-326784?utm_campaign=usage&utm_content=heart_sprout&utm_id=BMJ009&utm_medium=social&utm_source=twitter

02/07/2026

Almost all side effects on statin labels not caused by statins, finds major meta-analysis.

With no strong evidence to support statins causing 62 out 66 side effects currently listed in product labels, study authors recommend revising the current list of side effects on statin labelling to allow more informed decisions for patients.

👇 Figure: Effect of statin versus placebo on events listed in statin SmPCs, subdivided by component parts.

01/22/2026

A joint statement released by the ACC, ESC, AHA and WHF calls for urgent action to address environmental stressors as major, yet preventable, causes of .

The statement focuses on key environmental stressors, including noise/light pollution, climate change, chemical pollution, soil pollution, and air and water pollution, and outlines six overarching priority areas where a unified approach to prevention and policy can drive change.

Read more: https://bit.ly/4a4JU2f JACC Journals European Society of Cardiology American Heart Association World Heart Federation

01/05/2026

Use ’s latest infographic on respiratory infections to talk to your patients about 5️⃣ ways to protect their heart this flu season.

Explore additional resources on the 🆕 Respiratory Infections and Your Heart hub ➡️ https://bit.ly/49XYbOQ

12/23/2025

It’s a popular practice, and research shows it has real health benefits. A new diet that tricks your body into thinking it’s fasting may have similar benefits.

12/02/2025

Bicuspid aortic valve infective endocarditis (BAV-IE) patients incur delayed symptom-to-diagnosis time resulting in high IE complication burden, despite predominance of less virulent streptococcal causative microorganisms. These findings call for enhanced IE clinical suspicion in BAV patients and suggest antibiotic prophylaxis may be indicated in these patients.

Learn more in : https://bit.ly/3MxAbrT

11/21/2025

will help you cheer on your patients with tools and resources on the benefits of quitting smoking, the effects smoking has on the heart, tips to quit and more.

Learn more ➡️ https://bit.ly/47Rw0zB

11/15/2025

Now in : 2025 ACC Scientific Statement on the Management of in Adults With

Obesity drives risk for HF, CAD & , but targeted weight loss can change the game. Semaglutide & tirzepatide show promise in , but challenges remain. Clinicians must rethink how to diagnose, assess & manage obesity in HF.

🔗 Read the full statement here: https://bit.ly/43qdfRg